Amid the hoopla over President Obama's $215 million precision medicine plan, how will new drugs and diagnostics resulting from the initiative be regulated? That's the question Henry Miller poses in Forbes.
Amid the hoopla over President Obama's $215 million precision medicine plan, how will new drugs and diagnostics resulting from the initiative be regulated? That's the question Henry Miller poses in Forbes.